CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY - Get Free Report) saw a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 1,500 shares, a drop of 70.0% from the September 15th total of 5,000 shares. Based on an average daily volume of 13,700 shares, the days-to-cover ratio is currently 0.1 days. Based on an average daily volume of 13,700 shares, the days-to-cover ratio is currently 0.1 days.
Analyst Ratings Changes
A number of brokerages have recently issued reports on CHEOY. Zacks Research upgraded CochLear to a "hold" rating in a report on Monday, August 11th. Citigroup downgraded CochLear to a "neutral" rating in a report on Thursday, September 18th. Finally, Canaccord Genuity Group upgraded CochLear from a "hold" rating to a "strong-buy" rating in a report on Tuesday, October 7th. Two analysts have rated the stock with a Strong Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy".
Read Our Latest Stock Report on CHEOY
CochLear Stock Up 0.6%
Shares of CochLear stock traded up $0.58 during trading on Friday, reaching $92.93. The company's stock had a trading volume of 6,020 shares, compared to its average volume of 7,073. CochLear has a 1-year low of $74.76 and a 1-year high of $105.60. The company has a 50-day simple moving average of $96.62 and a two-hundred day simple moving average of $92.93.
CochLear Announces Dividend
The company also recently declared a dividend, which will be paid on Tuesday, October 28th. Shareholders of record on Monday, September 22nd will be given a dividend of $0.1045 per share. The ex-dividend date of this dividend is Friday, September 19th. This represents a yield of 122.0%.
CochLear Company Profile
(
Get Free Report)
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider CochLear, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CochLear wasn't on the list.
While CochLear currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
